top of page
Screenshot 2026-06-19 at 10.56.27 am.png

Presentations

Primary presentation, 63rd European Renal Association Congress 2026

Primary results of the FIND-CKD trial, including the pre-specified exploratory analysis of participants with glomerular diseases, and the individual-participant data meta-analysis of finerenone in CKD, INFINITY.

Click the image on the right to download the Powerpoint presentation.

Screenshot 2026-06-10 at 3.05.24 pm.png

Finerenone in patients with hypertensive nephropathy, European Society of Cardiology (ESC) Congress 2026

Results of the secondary analysis, evaluating the efficacy and safety of finerenone in patients with hypertensive nephropathy.

Click the image on the right to download the Powerpoint presentation.

Screenshot 2026-08-31 at 6.43.36 pm.png

Inter-relationship between cardiovascular disease, kidney disease progression, and treatment with finerenone in CKD: A pre-specified INFINITY analysis

A pre-specified INFINITY, exploring the bidirectional relationship between kidney and cardiovascular disease, and treatment with finerenone in CKD.

Click the image on the right to download the Powerpoint presentation.

Screenshot 2026-08-31 at 7.00.12 pm.png
TGI Logo 85K+2612.png
unsw_0.png
university-of-groningen.png

© 2035 by The George Institute for Global Health. All rights reserved.

bottom of page